Review: immune, metabolic and senescence signals in liver fibrosis
This review describes how immune activation, metabolic reprogramming and cellular senescence are interconnected during liver fibrosis and discusses possible therapeutic targets. [1]
Automatic summary · not editorially reviewed
The key findings
The review describes liver fibrosis as a dynamic and potentially reversible consequence of chronic liver injury. [1]
The authors state that immune activation, metabolic reprogramming and cellular senescence are closely interconnected during fibrogenesis. [1]
The review suggests that strategies targeting immunometabolic regulation, inflammasome activation and cellular senescence may offer promising avenues for reversing liver fibrosis. [1]
The source at a glance
- Study type / format
- Review article (abstract only)
- Population / context
- People with liver fibrosis and biological processes described in the review
- Summary based on
- Study abstract
- Original publication
- October 1, 2026
Fibrosis as dynamic, potentially reversible process
The review describes liver fibrosis as a dynamic and potentially reversible result of chronic liver injury. Persistent inflammation, metabolic disturbance and impaired tissue repair shape it. The authors say immune activation, metabolic reprogramming and cellular senescence are closely interconnected during fibrogenesis rather than independent processes. Together, they are described as driving activation of hepatic stellate cells, ductular reaction and excessive deposition of extracellular matrix.
Supporting source [1]
Regulatory nodes and new profiling methods
The review highlights regulatory nodes that integrate signals across these pathways: NF-κB, AMPK-mTOR, SIRT1/3, the NLRP3 inflammasome and the YAP/TAZ pathway. It also notes that multi-omics profiling, spatial transcriptomics and organoid-based models offer new opportunities to study this network at cellular and spatial resolution. The abstract does not report results from these methods; it presents them as opportunities.
Supporting source [1]
Therapeutic outlook in the review
From a translational perspective, the authors suggest that strategies targeting immunometabolic regulation, inflammasome activation and cellular senescence may offer promising avenues for restoring tissue homeostasis and reversing liver fibrosis. They especially mention combination with cell-type-specific intervention approaches. These are proposed avenues, not demonstrated treatments.
Supporting source [1]
How to interpret this
This explainer is based only on the abstract; the full text was not reviewed. The abstract reports no study design, sample, follow-up or outcome data, and the therapeutic strategies are proposed avenues, not demonstrated treatments.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Cao Y, Chen Y, Tam KHP. · europepmc.org · October 1, 2026